Excellent
Fully Aligned
Patient Risk:
Low
Summary
The evaluated warning claim is directly supported by the PROCRIT boxed warning and corresponding Warnings and Precautions sections, with no contradictions or unsupported additions.
Category Scores
Accurate Statements
ESAs increase risk of death, myocardial infarction, stroke, venous thromboembolism/thrombosis of vascular access, and tumor progression/recurrence.
BOXED WARNING states increased risk of death, myocardial infarction, stroke, venous thromboembolism, thrombosis of vascular access, and tumor progression or recurrence; Warnings and Precautions (5.1) further describes death/MI/stroke and thromboembolic events including thrombosis of hemodialysis vascular access; Warnings and Precautions (5.2) describes decreased survival/progression-free survival and increased risk of tumor progression or recurrence in cancer studies.
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
No unsafe or incorrect risk framing was introduced; the claim matches labeled boxed-warning risks.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement